0.00Open0.00Pre Close0 Volume0 Open Interest3.00Strike Price0.00Turnover283.29%IV-177.78%PremiumJan 17, 2025Expiry Date1.92Intrinsic Value100Multiplier25DDays to Expiry0.00Extrinsic Value100Contract SizeAmericanOptions Type-0.8401Delta0.3092Gamma0.56Leverage Ratio-0.0037Theta-0.0013Rho-0.47Eff Leverage0.0007Vega
CytomX Stock Discussion
$Damon Inc (DMN.US)$ Can be my PM gapper. Low float EV stock. IPO las...
📊⚡️📊
CytomX Therapeutics Announces First Patient Dosed with CX-801, a Dually-Masked Interferon-Alpha 2b PROBODY®, in a Phase 1 Study in Patients with Solid Tumors
No comment yet